SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-099033
Filing Date
2012-03-06
Accepted
2012-03-06 16:12:33
Documents
3
Period of Report
2012-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d311439d8k.htm 8-K 13803
2 PRESS RELEASE d311439dex991.htm EX-99.1 52496
3 GRAPHIC g311439ex99-1_pg001.jpg GRAPHIC 28598
  Complete submission text file 0001193125-12-099033.txt   107032
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 12670525
SIC: 2836 Biological Products, (No Diagnostic Substances)